Using the Standard Error of Measurement to Identify Important Changes on the Asthma Quality of Life Questionnaire

Overview

Journal Qual Life Res

Specialties Pharmacology
Rehabilitation Medicine

Date 2002 May 11

PMID 12003051

Citations 43

Authors

Kathleen W Wyrwich

William M Tierney

Fredric D Wolinsky

Affiliations

Soon will be listed here.

Abstract

Objectives: To establish a link between the minimal important difference (MID) and the standard error of measurement (SEM) for all responsive dimensions of the Asthma Quality of Life Questionnaire (AQLQ).

Methods: Secondary data analysis of baseline and follow-up interview data from 198 outpatients with asthma enrolled in a randomized controlled trial and receiving care at a major urban academic medical center's general medicine clinics. Domain statistics for baseline and follow-up interviews were examined for the AQLQ. The baseline SEM values were compared with established AQLQ MID standards using weighted kappa values.

Results: One SEM identified the MID in responsive AQLQ dimensions. Weighted kappa values (0.88-0.93) validated excellent agreement between these two criteria.

Conclusion: This is the third study to support using one SEM to identify important individual change in health-related quality of life (HRQoL) measures. However, refinement of the process for determining a measure's clinically meaningful differences is still needed to secure a link between the SEM and the identification of relevant HRQoL change over time.

Citing Articles

Changes in Quality of Life, Adherence, and Kinesiophobia in Patients with Hemophilia Treated with Extended Half-Life Treatment: Final Results of the LongHest Project.

Ucero-Lozano R, Perez-Llanes R, Cuesta-Barriuso R, Donoso-Ubeda E Pharmaceuticals (Basel). 2024; 17(7).

PMID: 39065686 PMC: 11279452. DOI: 10.3390/ph17070835.

LongHest project: A prospective, observational study of extended half-life treatment in the musculoskeletal health of patients with severe haemophilia A.

Cuesta-Barriuso R, Perez-Llanes R, Donoso-Ubeda E, Ucero-Lozano R Haemophilia. 2022; 28(5):857-864.

PMID: 35561281 PMC: 9541876. DOI: 10.1111/hae.14592.

The minimal perceived change: a formal model of the responder definition according to the patient's meaning of change for patient-reported outcome data analysis and interpretation.

Vanier A, Sebille V, Blanchin M, Hardouin J BMC Med Res Methodol. 2021; 21(1):128.

PMID: 34154521 PMC: 8215756. DOI: 10.1186/s12874-021-01307-9.

Determination of thresholds for minimally important difference and clinically important response on the functional outcomes of sleep questionnaire short version in adults with narcolepsy or obstructive sleep apnea.

Weaver T, Menno D, Bron M, Crosby R, Morris S, Mathias S Sleep Breath. 2021; 25(3):1707-1715.

PMID: 33394323 PMC: 8376693. DOI: 10.1007/s11325-020-02270-3.

Rollon-Ugalde V, Coello-Suanzes J, Lopez-Jimenez A, Herce-Lopez J, Toledano-Valero P, Montero-Martin J Med Oral Patol Oral Cir Bucal. 2020; 25(5):e576-e583.

PMID: 32683382 PMC: 7473439. DOI: 10.4317/medoral.23549.

References

Wenzel S, Lumry W, Manning M, Kalberg C, COX F, Emmett A . Efficacy, safety, and effects on quality of life of salmeterol versus albuterol in patients with mild to moderate persistent asthma. Ann Allergy Asthma Immunol. 1998; 80(6):463-70. DOI: 10.1016/S1081-1206(10)63068-2. View

Guyatt G, Nogradi S, Halcrow S, Singer J, Sullivan M, Fallen E . Development and testing of a new measure of health status for clinical trials in heart failure. J Gen Intern Med. 1989; 4(2):101-7. DOI: 10.1007/BF02602348. View

Guyatt G, BERMAN L, Townsend M, Pugsley S, Chambers L . A measure of quality of life for clinical trials in chronic lung disease. Thorax. 1987; 42(10):773-8. PMC: 460950. DOI: 10.1136/thx.42.10.773. View

Juniper E, Guyatt G, Willan A, Griffith L . Determining a minimal important change in a disease-specific Quality of Life Questionnaire. J Clin Epidemiol. 1994; 47(1):81-7. DOI: 10.1016/0895-4356(94)90036-1. View

Ware Jr J, Kemp J, Buchner D, Singer A, Nolop K, Goss T . The responsiveness of disease-specific and generic health measures to changes in the severity of asthma among adults. Qual Life Res. 1998; 7(3):235-44. DOI: 10.1023/a:1024946316424. View

Juniper E, Guyatt G, Feeny D, Ferrie P, Griffith L, Townsend M . Measuring quality of life in children with asthma. Qual Life Res. 1996; 5(1):35-46. DOI: 10.1007/BF00435967. View

Tierney W, Miller M, Hui S, McDonald C . Practice randomization and clinical research. The Indiana experience. Med Care. 1991; 29(7 Suppl):JS57-64. View

McDonald C, Overhage J, Tierney W, Dexter P, Martin D, Suico J . The Regenstrief Medical Record System: a quarter century experience. Int J Med Inform. 1999; 54(3):225-53. DOI: 10.1016/s1386-5056(99)00009-x. View

Guyatt G, Juniper E, Walter S, Griffith L, Goldstein R . Interpreting treatment effects in randomised trials. BMJ. 1998; 316(7132):690-3. PMC: 1112685. DOI: 10.1136/bmj.316.7132.690. View

10.

Anie K, Jones P, Hilton S, Anderson H . A computer-assisted telephone interview technique for assessment of asthma morbidity and drug use in adult asthma. J Clin Epidemiol. 1996; 49(6):653-6. DOI: 10.1016/0895-4356(95)00583-8. View

11.

Stephens R, Hopwood P, Girling D, Machin D . Randomized trials with quality of life endpoints: are doctors' ratings of patients' physical symptoms interchangeable with patients' self-ratings?. Qual Life Res. 1997; 6(3):225-36. DOI: 10.1023/a:1026458604826. View

12.

Norman G, Stratford P, Regehr G . Methodological problems in the retrospective computation of responsiveness to change: the lesson of Cronbach. J Clin Epidemiol. 1997; 50(8):869-79. DOI: 10.1016/s0895-4356(97)00097-8. View

13.

Juniper E, Johnston P, Borkhoff C, Guyatt G, Boulet L, Haukioja A . Quality of life in asthma clinical trials: comparison of salmeterol and salbutamol. Am J Respir Crit Care Med. 1995; 151(1):66-70. DOI: 10.1164/ajrccm.151.1.7812574. View

14.

McHorney C, TARLOV A . Individual-patient monitoring in clinical practice: are available health status surveys adequate?. Qual Life Res. 1995; 4(4):293-307. DOI: 10.1007/BF01593882. View

15.

Jaeschke R, Singer J, Guyatt G . Measurement of health status. Ascertaining the minimal clinically important difference. Control Clin Trials. 1989; 10(4):407-15. DOI: 10.1016/0197-2456(89)90005-6. View

16.

Naylor C, Llewellyn-Thomas H . Can there be a more patient-centred approach to determining clinically important effect sizes for randomized treatment trials?. J Clin Epidemiol. 1994; 47(7):787-95. DOI: 10.1016/0895-4356(94)90176-7. View

17.

Wyrwich K, Nienaber N, Tierney W, Wolinsky F . Linking clinical relevance and statistical significance in evaluating intra-individual changes in health-related quality of life. Med Care. 1999; 37(5):469-78. DOI: 10.1097/00005650-199905000-00006. View

18.

Wyrwich K, Tierney W, Wolinsky F . Further evidence supporting an SEM-based criterion for identifying meaningful intra-individual changes in health-related quality of life. J Clin Epidemiol. 1999; 52(9):861-73. DOI: 10.1016/s0895-4356(99)00071-2. View

19.

Wolinsky F, Wyrwich K, Nienaber N, Tierney W . Generic versus disease-specific health status measures. An example using coronary artery disease and congestive heart failure patients. Eval Health Prof. 1998; 21(2):216-43. DOI: 10.1177/016327879802100205. View

20.

Juniper E, Guyatt G, Ferrie P, Griffith L . Measuring quality of life in asthma. Am Rev Respir Dis. 1993; 147(4):832-8. DOI: 10.1164/ajrccm/147.4.832. View